Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Birner

Showing results (31-40 of 138) with videos related to

Pageof 14
Sort By:
International Journal of Cancer|July 13, 2002
DNA topoisomerase IIalpha predicts progression-free and overall survival in pediatric malignant non-brainstem gliomasMarkus Bredel, Ian F Pollack, Ronald L Hamilton, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 25, 2013
HER2 gene amplification and protein expression in pancreatic ductal adenocarcinomasKlaus Aumayr, Afschin Soleiman, Klaus Sahora, et al.
Clinical & Experimental Metastasis|November 20, 2012
Podoplanin expressing cancer associated fibroblasts are associated with unfavourable prognosis in adenocarcinoma of the esophagusSebastian F Schoppmann, Bettina Jesch, Martin F Riegler, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 30, 2013
Phosphorylation of STAT3 correlates with HER2 status, but not with survival in pancreatic ductal adenocarcinomaOskar Koperek, Klaus Aumayr, Martin Schindl, et al.
Cancer Letters|February 5, 2013
Downregulation of phosphatidylethanolamine binding protein 1 associates with clinical risk factors in gastrointestinal stromal tumors, but not with activation of the RAF-1-MEK-ETV1 pathwaySebastian F Schoppmann, Andrea Beer, Nadine Nirtl, et al.
Cancer Investigation|June 5, 2014
Downregulation of CIC does not associate with overexpression of ETV1 or MAP kinase pathway activation in gastrointestinal stromal tumorsSebastian F Schoppmann, Gerda Ricken, Aysegül Ilhan-Mutlu, et al.
Pathology Oncology Research : POR|July 30, 2017
HER2 and TOP2A Gene Amplification and Protein Expression in Upper Tract Urothelial CarcinomasKlaus Aumayr, Tobias Klatte, Barbara Neudert, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600EIldiko Mesteri, Günther Bayer, Jochen Meyer, et al.
Histopathology|April 8, 2015
Evaluation of tyrosine kinase receptors in brain metastases of clear cell renal cell carcinoma reveals cMet as a negative prognostic factorAna-Iris Schiefer, Ildiko Mesteri, Anna S Berghoff, et al.
Journal of Clinical Pathology|March 27, 2012
Human homologue for Caenorhabditis elegans CUL-4 protein overexpression is associated with malignant potential of epithelial ovarian tumours and poor outcome in carcinomaPeter Birner, Alexandra Schoppmann, Monika Schindl, et al.
Pageof 14

Showing results (31-40 of 138) with videos related to

Sort By:
Pageof 14
International Journal of Cancer|July 13, 2002
DNA topoisomerase IIalpha predicts progression-free and overall survival in pediatric malignant non-brainstem gliomasMarkus Bredel, Ian F Pollack, Ronald L Hamilton, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 25, 2013
HER2 gene amplification and protein expression in pancreatic ductal adenocarcinomasKlaus Aumayr, Afschin Soleiman, Klaus Sahora, et al.
Clinical & Experimental Metastasis|November 20, 2012
Podoplanin expressing cancer associated fibroblasts are associated with unfavourable prognosis in adenocarcinoma of the esophagusSebastian F Schoppmann, Bettina Jesch, Martin F Riegler, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 30, 2013
Phosphorylation of STAT3 correlates with HER2 status, but not with survival in pancreatic ductal adenocarcinomaOskar Koperek, Klaus Aumayr, Martin Schindl, et al.
Cancer Letters|February 5, 2013
Downregulation of phosphatidylethanolamine binding protein 1 associates with clinical risk factors in gastrointestinal stromal tumors, but not with activation of the RAF-1-MEK-ETV1 pathwaySebastian F Schoppmann, Andrea Beer, Nadine Nirtl, et al.
Cancer Investigation|June 5, 2014
Downregulation of CIC does not associate with overexpression of ETV1 or MAP kinase pathway activation in gastrointestinal stromal tumorsSebastian F Schoppmann, Gerda Ricken, Aysegül Ilhan-Mutlu, et al.
Pathology Oncology Research : POR|July 30, 2017
HER2 and TOP2A Gene Amplification and Protein Expression in Upper Tract Urothelial CarcinomasKlaus Aumayr, Tobias Klatte, Barbara Neudert, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600EIldiko Mesteri, Günther Bayer, Jochen Meyer, et al.
Histopathology|April 8, 2015
Evaluation of tyrosine kinase receptors in brain metastases of clear cell renal cell carcinoma reveals cMet as a negative prognostic factorAna-Iris Schiefer, Ildiko Mesteri, Anna S Berghoff, et al.
Journal of Clinical Pathology|March 27, 2012
Human homologue for Caenorhabditis elegans CUL-4 protein overexpression is associated with malignant potential of epithelial ovarian tumours and poor outcome in carcinomaPeter Birner, Alexandra Schoppmann, Monika Schindl, et al.
Pageof 14